AEHR Plunges to Loss on Revenue Drop, Soaring Costs

TL;DR

**AEHR's latest quarter is a red flag: revenue down, costs up, and a swing to a net loss means this stock is a sell until they prove they can turn it around.**

AI Summary

AEHR Test Systems reported a significant financial downturn for the three months ended August 29, 2025, with revenue decreasing by 16.4% to $10.969 million from $13.119 million in the prior year. The company swung to a net loss of $2.084 million, or $(0.07) per diluted share, compared to a net income of $0.660 million, or $0.02 per diluted share, in the same period last year. Gross profit declined sharply by 47.4% to $3.719 million from $7.078 million, primarily due to increased cost of revenue, which rose to $7.250 million from $6.041 million. Operating expenses increased to $7.785 million, including $219 thousand in restructuring charges not present in the prior year. Cash and cash equivalents decreased to $22.708 million from $24.529 million at May 30, 2025, and net cash used in operating activities was $0.282 million, a reversal from $2.380 million provided in the prior year. The company also saw a substantial increase in purchases of property and equipment, rising to $1.391 million from $0.197 million.

Why It Matters

This filing reveals a concerning shift for AEHR, moving from profitability to a net loss, which could signal weakening demand in the semiconductor test equipment market or increased competitive pressures. The significant decline in revenue and gross profit, coupled with rising operating expenses and restructuring charges, suggests operational challenges that could erode investor confidence. For employees, restructuring charges might indicate potential job impacts. Customers could face uncertainty regarding future product development or support if financial performance continues to deteriorate. The broader market may view this as a bellwether for the semiconductor equipment sector, especially given the concentration of revenue from a few key customers, making AEHR vulnerable to customer-specific downturns.

Risk Assessment

Risk Level: high — The company reported a net loss of $2.084 million for the quarter, a significant reversal from a $0.660 million net income in the prior year. Revenue decreased by 16.4% to $10.969 million, and gross profit fell by 47.4% to $3.719 million, indicating severe pressure on both top-line growth and profitability. Furthermore, the company has high customer concentration, with Customer A accounting for 42.6% of revenue and Customer B for 21.8% in the current quarter, making AEHR highly susceptible to the business cycles or strategic shifts of these few clients.

Analyst Insight

Investors should consider reducing their exposure to AEHR given the sharp decline in revenue, gross profit, and the swing to a net loss. Monitor future filings closely for signs of revenue stabilization, improved gross margins, and a reduction in operating expenses, particularly restructuring charges, before considering a re-entry. The high customer concentration also warrants caution.

Financial Highlights

revenue

$10.969M

total Assets

$144.092M

total Debt

$21.698M

net Income

$(2.084)M

eps

$(0.07)

gross Margin

33.9%

cash Position

$22.708M

revenue Growth

-16.4%

Key Numbers

• $10.969M — Revenue (Decreased by 16.4% from $13.119M in Q1 2024)
• $(2.084)M — Net Loss (Swing from $0.660M net income in Q1 2024)
• $(0.07) — Diluted EPS (Decreased from $0.02 in Q1 2024)
• $3.719M — Gross Profit (Decreased by 47.4% from $7.078M in Q1 2024)
• $7.250M — Cost of Revenue (Increased from $6.041M in Q1 2024)
• $219K — Restructuring Charges (New expense in Q1 2025, not present in Q1 2024)
• $22.708M — Cash and Cash Equivalents (Decreased from $24.529M at May 30, 2025)
• $(0.282)M — Net Cash from Operating Activities (Reversal from $2.380M provided in Q1 2024)
• 42.6% — Customer A Revenue Concentration (Percentage of total revenues for Q1 2025)
• $1.391M — Purchases of Property and Equipment (Increased from $0.197M in Q1 2024)

Key Players & Entities

• AEHR TEST SYSTEMS (company) — Registrant
• Customer A (company) — 42.6% of total revenues for the three months ended August 29, 2025
• Customer B (company) — 21.8% of total revenues for the three months ended August 29, 2025
• Customer C (company) — 11.6% of total revenues for the three months ended August 29, 2025
• NASDAQ Capital Market (regulator) — Exchange where Common Stock is registered
• SEC (regulator) — Securities and Exchange Commission
• FASB (regulator) — Financial Accounting Standards Board

FAQ

Risk Factors

• Revenue Concentration [high — financial]: The company's revenue is heavily reliant on a single customer, representing 42.6% of total revenues in Q1 2025. A significant loss of this customer could severely impact financial performance.
• Increased Cost of Revenue [high — operational]: Cost of revenue increased by 20.0% to $7.250 million from $6.041 million in the prior year's comparable period. This led to a sharp decline in gross profit.
• Restructuring Charges [medium — operational]: The company incurred $219 thousand in restructuring charges in the current quarter, which were not present in the prior year. These charges contributed to the net loss.
• Deteriorating Operating Performance [high — financial]: The company swung to a net loss of $2.084 million from a net income of $0.660 million in the prior year. Income from operations also turned negative, falling to a loss of $4.066 million from income of $159 thousand.
• Reduced Cash Flow from Operations [high — financial]: Net cash used in operating activities was $0.282 million, a significant reversal from $2.380 million provided in the prior year. This indicates a weakening ability to generate cash from core business activities.
• Increased Capital Expenditures [medium — financial]: Purchases of property and equipment increased substantially to $1.391 million from $0.197 million in the prior year. While this may indicate investment in future growth, it also drains current cash resources.

Industry Context

AEHR Test Systems operates in the semiconductor testing equipment market. This industry is characterized by high R&D investment, cyclical demand tied to semiconductor manufacturing cycles, and intense competition from global players. Recent trends include increasing complexity of chips requiring more advanced testing solutions and a growing demand for outsourced semiconductor assembly and test (OSAT) services.

Regulatory Implications

As a publicly traded company, AEHR Test Systems is subject to SEC regulations, including timely and accurate financial reporting. Any misstatements or failures to comply with accounting standards could lead to investigations, fines, and reputational damage. The company must also adhere to general business regulations in the jurisdictions where it operates.

What Investors Should Do

1. Monitor customer concentration: The significant reliance on a single customer (42.6% of revenue) poses a substantial risk. Investors should closely watch any developments related to this customer relationship.
2. Analyze cost management: The sharp increase in cost of revenue and subsequent decline in gross margin require scrutiny. Investors should look for management's strategies to control costs and improve efficiency.
3. Evaluate capital expenditure rationale: The significant increase in property and equipment purchases needs to be understood in the context of future growth drivers and potential return on investment.
4. Assess cash flow generation: The reversal from positive to negative operating cash flow is a key concern. Investors should track improvements in cash flow generation in subsequent periods.

Glossary

Cost of revenue

The direct costs attributable to the production or purchase of the goods sold by a company. (An increase in cost of revenue without a corresponding increase in revenue directly impacts gross profit and profitability.)

Restructuring charges

Costs associated with significant reorganizations of a company's operations, such as layoffs, facility closures, or business divestitures. (These are one-time or infrequent expenses that can negatively impact net income in the period they are recognized.)

Net cash used in operating activities

The amount of cash a company has spent on its core business operations during a period, after accounting for cash generated. (A negative number indicates the company is spending more cash on operations than it is generating, which can be a sign of financial strain.)

Diluted EPS

Earnings per share calculated after considering the effect of all potential dilutive common shares, such as stock options and convertible securities. (This provides a more conservative view of a company's profitability on a per-share basis.)

Year-Over-Year Comparison

Compared to the prior year's comparable period, AEHR Test Systems experienced a significant downturn. Revenue decreased by 16.4% to $10.969 million, and the company swung from a net income of $0.660 million to a net loss of $2.084 million. Gross profit margins were severely impacted by a 20.0% increase in the cost of revenue, leading to a 47.4% decline in gross profit. Operating expenses also rose, partly due to new restructuring charges, and cash flow from operations reversed from a positive inflow to a net outflow.

Key Financial Figures

• $0.01 — h registered Common Stock par value of $0.01 per share AEHR The NASDAQ Capital M

Filing Documents

• aehr_10q.htm (10-Q) — 704KB
• aehr_ex311.htm (EX-31.1) — 14KB
• aehr_ex312.htm (EX-31.2) — 14KB
• aehr_ex321.htm (EX-32.1) — 6KB
• aehr_ex322.htm (EX-32.2) — 6KB
• 0001654954-25-011582.txt ( ) — 4092KB
• aehr-20250829.xsd (EX-101.SCH) — 38KB
• aehr-20250829_lab.xml (EX-101.LAB) — 234KB
• aehr-20250829_cal.xml (EX-101.CAL) — 48KB
• aehr-20250829_pre.xml (EX-101.PRE) — 202KB
• aehr-20250829_def.xml (EX-101.DEF) — 94KB
• aehr_10q_htm.xml (XML) — 605KB

FINANCIAL INFORMATION

PART I FINANCIAL INFORMATION Item 1.

Financial Statements (Unaudited)

Financial Statements (Unaudited) 3 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 18 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 23 Item 4.

Controls and Procedures

Controls and Procedures 23

OTHER INFORMATION

PART II OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 24 Item 1A.

Risk Factors

Risk Factors 24 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 24 Item 3. Defaults Upon Senior Securities 24 Item 4. Mine Safety Disclosures 24 Item 5. Other Information 24 Item 6. Exhibits 25

SIGNATURES

SIGNATURES 26 2 Table of Contents

— FINANCIAL INFORMATION

PART I — FINANCIAL INFORMATION

Financial Statements (unaudited)

Item 1. Financial Statements (unaudited) AEHR TEST SYSTEMS CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) August 29, May 30, (In thousands, except par value) 2025 2025 ASSETS Current assets: Cash and cash equivalents $ 22,708 $ 24,529 Accounts receivable 13,055 14,191 Inventories 41,842 41,997 Prepaid expenses and other current assets 6,447 8,061 Total current assets 84,052 88,778 Property and equipment, net 9,001 8,969 Goodwill 10,719 10,719 Intangible assets, net 10,439 10,781 Deferred tax assets, net 19,875 19,114 Operating lease right-of-use assets, net 9,422 9,601 Other non-current assets 584 546 Total assets $ 144,092 $ 148,508 LIABILITIES AND SHAREHOLDERS EQUITY Current liabilities: Accounts payable $ 3,380 $ 6,728 Accrued expenses and other current liabilities 6,509 6,020 Operating lease liabilities, short-term 905 909 Deferred revenue, short-term 1,119 1,981 Total current liabilities 11,913 15,638 Operating lease liabilities, long-term 9,710 9,921 Deferred revenue, long-term 35 36 Other long-term liabilities 40 42 Total liabilities 21,698 25,637 Commitments and contingencies (Note 6) Shareholders equity: Preferred stock, $ 0.01 par value: Authorized: 10,000 shares; Issued and outstanding: none - - Common stock, $ 0.01 par value: Authorized: 75,000 shares; Issued and outstanding: 29,973 shares and 29,877 shares at August 29, 2025 and May 30, 2025, respectively 300 299 Additional paid-in capital 147,333 145,758 Accumulated other comprehensive loss ( 95 ) ( 126 ) Accumulated deficit ( 25,144 ) ( 23,060 ) Total shareholders' equity 122,394 122,871 Total liabilities and shareholders equity $ 144,092 $ 148,508 See accompanying Notes to Condensed Consolidated Financial Statements (unaudited) 3 Table of Contents AEHR TEST SYSTEMS CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

View Full Filing

View this 10-Q filing on SEC EDGAR